REFERENCES
- Cuttner J., Troy K.M., Funaro L., Brenden R., Bottone E.J. Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. American Journal of Medicine 1986; 81: 771–774
- Epstein J.B., Truelove E.L., Izutzu K.T. Oral candidiasis: pathogenesis and host defense. Reviews of Infectious Diseases 1984; 6: 96–106
- Joy M. Oral candidiasis and AIDS. New England Journal of Medicine 1984; 311: 1378–1379
- Kirkpatrick C.H. Host factors in defense against fungal infections. American Journal of Medicine 1984; 77(4D)1–12
- Klein R.S., Carol A.H., Small C.B., Moll B., Lesser M., Friedland G.H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New England Journal of Medicine 1984; 311: 354–358
- Maksymiuk A.W., Thongprasert S., Hopfer R., Luna M., Fainstein V., Bodey G.P. Systemic candidiasis in cancer patients. American Journal of Medicine 1984; 77(4D)20–27
- Quintiliani R., Owens N.J., Quercia R.A., Klimek J.J., Nightingale C.H. Treatment and prevention of oropharyngeal candidiasis. American Journal of Medicine 1984; 77(4D)44–48
- Tavitian A., Raufman J.P., Rosenthal L.E. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1986; 104: 54–55
- Trier J.S., Bjorkman D.J. Esophageal, gastric and intestinal candidiasis. American Journal of Medicine 1984; 77(4D)39–43